Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20929 / DOSAGE - SUSPENSION;INHALATION - 0.25MG/2ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X) | BUDESONIDE | 0.5mg in 2 |
Inactive Ingredients
| Ingredient Name | Cardinal Health | A-S Medication Solutions | Actavis Pharma, Inc. | American Health Packaging | Amneal Pharmaceuticals of New York LLC | Catalent Pharma Solutions, LLC | Cipla USA Inc. | Exelan Pharmaceuticals, Inc. | NorthStar RxLLC | Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals, Inc. | Apotex Corp. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||||||||||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||||||||||
| EDETATE DISODIUM(7FLD91C86K) | ||||||||||||
| POLYSORBATE 80(6OZP39ZG8H) | ||||||||||||
| SODIUM CHLORIDE (451W47IQ8X) | ||||||||||||
| Sodium Chloride(451W47IQ8X) | ||||||||||||
| SODIUM CITRATE(1Q73Q2JULR) | ||||||||||||
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||||||||||
| TRISODIUM CITRATE DIHYDRATE(B22547B95K) | ||||||||||||
| WATER(059QF0KO0R) |
